Search research articles
Contact Us
Filters
Showing results (211-220 of 242) with videos related to
Page
of 25
Sort By:
Oncogene
|
December 20, 2011
Deubiquitination of EGFR by Cezanne-1 contributes to cancer progression
F Pareja, D A Ferraro, C Rubin, et al.
Oncogene
|
January 29, 2014
Elafin drives poor outcome in high-grade serous ovarian cancers and basal-like breast tumors
S I Labidi-Galy, A Clauss, V Ng, et al.
Oncogene
|
July 8, 2014
Autophagy mediates HIF2α degradation and suppresses renal tumorigenesis
X-D Liu, J Yao, D N Tripathi, et al.
NPJ Breast Cancer
|
December 15, 2017
A feasibility study of neoadjuvant talazoparib for operable breast cancer patients with a germline <i>BRCA</i> mutation demonstrates marked activity
J K Litton, M Scoggins, D L Ramirez, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 6, 2016
Utility of a molecular prescreening program in advanced colorectal cancer for enrollment on biomarker-selected clinical trials
M J Overman, V Morris, B Kee, et al.
Cancer Research
|
August 2, 2001
Genetic analysis of early- versus late-stage ovarian tumors
V Shridhar, J Lee, A Pandita, et al.
Oncogene
|
July 28, 2015
Grb2 depletion under non-stimulated conditions inhibits PTEN, promotes Akt-induced tumor formation and contributes to poor prognosis in ovarian cancer
Z Timsah, Z Ahmed, C Ivan, et al.
JCO Precision Oncology
|
September 14, 2019
Expanded analysis of secondary germline findings from matched tumor/normal sequencing identifies additional clinically significant mutations
E Ileana Dumbrava, L Brusco, M Daniels, et al.
British Journal of Cancer
|
October 11, 2012
Patterns of genomic loss of heterozygosity predict homologous recombination repair defects in epithelial ovarian cancer
V Abkevich, K M Timms, B T Hennessy, et al.
Oncogene
|
February 3, 2015
Functional proteomics identifies miRNAs to target a p27/Myc/phospho-Rb signature in breast and ovarian cancer
E G Seviour, V Sehgal, Y Lu, et al.
Page
of 25
Search research articles
Search
Showing results (211-220 of 242) with videos related to
Sort By:
Page
of 25
Oncogene
|
December 20, 2011
Deubiquitination of EGFR by Cezanne-1 contributes to cancer progression
F Pareja, D A Ferraro, C Rubin, et al.
Oncogene
|
January 29, 2014
Elafin drives poor outcome in high-grade serous ovarian cancers and basal-like breast tumors
S I Labidi-Galy, A Clauss, V Ng, et al.
Oncogene
|
July 8, 2014
Autophagy mediates HIF2α degradation and suppresses renal tumorigenesis
X-D Liu, J Yao, D N Tripathi, et al.
NPJ Breast Cancer
|
December 15, 2017
A feasibility study of neoadjuvant talazoparib for operable breast cancer patients with a germline <i>BRCA</i> mutation demonstrates marked activity
J K Litton, M Scoggins, D L Ramirez, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 6, 2016
Utility of a molecular prescreening program in advanced colorectal cancer for enrollment on biomarker-selected clinical trials
M J Overman, V Morris, B Kee, et al.
Cancer Research
|
August 2, 2001
Genetic analysis of early- versus late-stage ovarian tumors
V Shridhar, J Lee, A Pandita, et al.
Oncogene
|
July 28, 2015
Grb2 depletion under non-stimulated conditions inhibits PTEN, promotes Akt-induced tumor formation and contributes to poor prognosis in ovarian cancer
Z Timsah, Z Ahmed, C Ivan, et al.
JCO Precision Oncology
|
September 14, 2019
Expanded analysis of secondary germline findings from matched tumor/normal sequencing identifies additional clinically significant mutations
E Ileana Dumbrava, L Brusco, M Daniels, et al.
British Journal of Cancer
|
October 11, 2012
Patterns of genomic loss of heterozygosity predict homologous recombination repair defects in epithelial ovarian cancer
V Abkevich, K M Timms, B T Hennessy, et al.
Oncogene
|
February 3, 2015
Functional proteomics identifies miRNAs to target a p27/Myc/phospho-Rb signature in breast and ovarian cancer
E G Seviour, V Sehgal, Y Lu, et al.
Page
of 25